D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, Endothelium-575 dependent contractions and endothelial dysfunction in human hyper-576 tension, Pharmacol, vol.157, pp.527-563, 2009.

J. Davignon and P. Ganz, Role of endothelial dysfunction in atherosclerosis, p.579

, Circul ati on, vol.109, pp.27-32, 2004.

S. Moncada, R. M. Palmer, and E. A. Higgs, Nitric oxide, p.582

, Pharmacol Rev, vol.43, pp.109-151, 1991.

H. Cai and D. G. Harrison, Endothelial dysfunction in cardiovascular diseases, p.585

, The role of oxidant stress, Circ Res, vol.87, pp.840-844, 2000.

C. Napoli, F. De-nigris, S. Williams-ignarro, O. Pignalosa, and V. Sica,

, Nitric oxide and atherosclerosis: An update, Nitric Oxide, vol.589

S. Ji-yeon, Nitric oxide and pulmonary hypertension, Anesthesiol, vol.591, pp.4-14, 2010.

J. Loscalzo, Nitric oxide insufficiency, platelet activation, and arterial 593 thrombosis, Circ Res, vol.88, pp.756-62, 2001.
DOI : 10.1161/hh0801.089861

J. P. Bolaños and A. Almeida, Roles of nitric oxide in brain hypoxia-ischemia, vol.596

, Biochim Biophys Acta, vol.1411, pp.415-451, 1999.

J. Tamargo, R. Caballero, R. Gómez, and E. Delpón, Cardiac electrophysio-599 logical effects of nitric oxide, Cardiovasc Res, vol.87, pp.593-600, 2010.

,

N. Hogg, R. J. Singh, and B. Kalyanaraman, The role of glutathione in the 602 transport and catabolism of nitric oxide, FEBS Lett, vol.382, p.603, 1996.

,

D. A. Riccio, K. P. Dobmeier, E. M. Hetrick, B. J. Privett, and H. S. Paul, , p.605

. Mh, Nitric oxide-releasing S-nitrosothiol-modified xerogels

E. J. Langford, A. S. Brown, R. J. Wainwright, A. J. De-belder, and M. R. Thomas, , p.609

R. E. Smith, Inhibition of platelet activity by S-nitrosoglutathione 610 during coronary angioplasty, Lancet, vol.344, pp.1458-60, 1994.

R. J. Macallister, A. L. Calver, J. Riezebos, J. Collier, and P. Vallance, Relative 613 potency and arteriovenous selectivity of nitrovasodilators on human 614 blood vessels: An insight into the targeting of nitric oxide delivery, p.615

, Pharmacol Exp Ther, vol.273, pp.154-60, 1995.

T. Rassaf, P. Kleinbongard, M. Preik, A. Dejam, P. Gharini et al., , p.617

, Plasma nitrosothiols contribute to the systemic vasodilator effects of 618 intravenously applied NO: Experimental and clinical study on the fate of 619 NO in human blood, Circ Res, vol.91, pp.470-477, 2002.

A. J. Friedman, K. Blecher, D. Schairer, C. Tuckman-vernon, and P. Nacharaju, , p.622

D. Sanchez, Improved antimicrobial efficacy with nitric oxide 623 releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide, vol.624, pp.381-387, 2011.

D. E. Jensen, G. K. Belka, D. Bois, and G. C. , S-Nitrosoglutathione is a substrate 631 for rat alcohol dehydrogenase class III isoenzyme, Biochem J, vol.632, issue.2, pp.659-68, 1998.

R. L. Bateman, D. Rauh, B. Tavshanjian, and K. M. Shokat, Human carbonyl 634 reductase 1 is an S-nitrosoglutathione reductase, J Biol Chem, vol.635, pp.35756-62, 2008.

Q. Chen, R. E. Sievers, M. Varga, S. Kharait, D. J. Haddad et al.,

A. B. Seabra, G. F. De-souza, L. L. Da-rocha, M. N. Eberlin, M. De-oliveira et al., Solid films of 645 blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-646 nitrosoglutathione and nitric oxide release, Pharmacological inhibition of S-nitrosoglutathione reductase improves 638 endothelial vasodilatory function in rats in vivo, vol.639, pp.994-647, 2004.

A. De-mel, N. Naghavi, and B. G. Cousins,

A. Darbyshire, Nitric oxide-eluting nanocomposite for cardiovas-650 cular implants, J Mater Sci Mater Med, vol.25, pp.917-946, 2014.

,

P. D. Marcato, L. F. Adami, R. De-melo-barbosa, P. S. Melo, and I. R. Ferreira,

L. Paula, Development of a sustained-release system for nitric oxide 654 delivery using alginate/chitosan nanoparticles, Curr Nanosci, vol.655, pp.1-7, 2013.

, Glutathione and S-nitrosoglutathione in alginate/chitosan nanoparticles, p.658

. Cytotoxicity, JPCS, vol.304, p.12045, 2011.

S. U. Shah, N. Martinho, M. Socha, P. Reis, C. Gibaud et al., Synthesis and 661 characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a 662 nitric oxide donor, Expert Opin Drug Deliv, vol.12, pp.1-15, 2015.

W. Wu, C. Gaucher, R. Diab, I. Fries, Y. L. Xiao et al., Time lasting 665 S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-666 nitrosation, Pharm Biopharm, vol.89, pp.1-8, 2015.

W. Wu, C. Gaucher, I. Fries, X. M. Hu, P. Maincent et al.,

S. N. Bhattacharya, M. R. Kamal, and R. K. Gupta, Polymer nanocomposite particles of S-nitrosoglutathione: A suitable 670 formulation for protection and sustained oral delivery, Pharm, vol.671, pp.354-61, 2015.

, Gomez-Orellana I. Strategies to improve oral drug bioavailability. Ex-676 pert Opin, Drug Deliv, vol.29, pp.419-452, 2005.

H. Zhang, J. Zhang, and J. B. Streisand, Oral mucosal drug delivery: Clinical 679 pharmacokinetics and therapeutic applications, Clin Pharmacokinet, vol.680, pp.661-80, 2002.

V. Dodane, A. Khan, M. Merwin, and J. R. , Effect of chitosan on epthelial 683 permeability and structure, Pharm, vol.182, pp.21-32, 1999.

M. Thanou, J. C. Verhoef, and H. E. Junginger, Oral drug absorption 685 enhancement by chitosan and its derivatives, Adv Drug Deliv Rev, vol.686, pp.231-240, 2001.

M. Parent, F. Dahboul, R. Schneider, I. Clarot, P. Maincent et al., 688 A complete physicochemical identity card of S-nitrosoglutathione, Curr 689 Pharm Anal, vol.9, pp.31-42, 2013.

J. Sun, X. Zhang, M. Broderick, and H. Fein, Measurement of nitric oxide 691 production in biological systems by using griess reaction assay, Sensors, vol.692, pp.276-84, 2003.

C. Y. Liu, M. Zhao, C. Y. Ren, Y. Gp, P. F. Li et al.,

, Anal Chem, vol.37, pp.1463-1470, 2009.

J. H. Lim, S. K. You, J. S. Baek, C. J. Hwang, Y. G. Na et al., , p.698

, Preparation and evaluation of polymeric microparticulates for improving 699 cellular uptake of gemcitabine, Nanomedicine, vol.7, pp.2307-2321, 2012.

,

M. Parent, A. Boudier, I. Fries, A. Gosty?ska, M. Rychter et al., Nitric 702 oxide-eluting scaffolds and their interaction with smooth muscle cells in 703

, J Biomed Mater Res A, vol.103, pp.3303-3314, 2015.

P. J. Hutchinson, R. M. Palmer, and S. Moncada, Comparative pharmacology, p.706

, EDRF and nitric oxide on vascular strips, Pharmacol, vol.141, p.707, 1987.

, , vol.87, pp.90563-90565

T. R. Everett, I. B. Wilkinson, A. A. Mahendru, C. M. Mceniery, and S. F. Garner, , p.709

A. H. Goodall, S-Nitrosoglutathione improves haemodynamics in 710 early-onset pre-eclampsia, Clin Pharmacol, vol.78, pp.660-669, 2014.

,

A. S. Hasan, M. Socha, A. Lamprecht, F. E. Ghazouani, and A. Sapin,

M. , Effect of the microencapsulation of nanoparticles on the 714 reduction of burst release, Pharm, vol.344, pp.53-61, 2007.

A. B. Seabra, D. Oliveira, and M. G. , Poly(vinyl alcohol) and poly(vinyl 717

, pyrrolidone) blended films for local nitric oxide release, Biomaterials, vol.718, pp.3773-82, 2004.

A. B. Seabra, A. Fitzpatrick, J. Paul, D. Oliveira, M. G. Weller et al., Topically 720 applied S-nitrosothiol-containing hydrogels as experimental, p.721

, macological nitric oxide donors in human skin, Dermatol, vol.722, pp.977-83, 2004.

M. George and T. E. Abraham, Polyionic hydrocolloids for the intestinal 724 delivery of protein drugs: Alginate and chitosan -a review, J Control 725 Release, vol.114, pp.1-14, 2006.

G. Garrait, E. Beyssac, and M. Subirade, Development of a novel drug delivery 727 system: Chitosan nanoparticles entrapped in alginate microparticles, J 728 Microencapsul, vol.31, pp.363-72, 2014.

B. H. Bajka, N. M. Rigby, K. L. Cross, A. Macierzanka, and A. R. Mackie, The 731

, Colloids Surf B: Biointerfaces, vol.135, pp.73-80, 2015.

C. Gaucher, A. Boudier, F. Dahboul, M. Parent, and P. Leroy,

, denitrosation in cardiovascular pathologies: Facts and concepts for the 736 rational design of S-nitrosothiols, Curr Pharm Des, vol.19, 2013.

J. L. Alencar, I. Lobysheva, M. Geffard, M. Sarr, and C. Schott,

. Vb, Role of S-nitrosation of cysteine residues in long-lasting 739

S. I. Khan, E. A. Abourashed, I. A. Khan, and L. A. Walker, Transport of harman 742 alkaloids across Caco-2 cell monolayers, Chem Pharm Bull, vol.743, pp.394-401, 2004.

I. L. Megson, I. R. Greig, G. A. Gray, D. J. Webb, and A. R. Butler, Prolonged effect of a 745 novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral 746 arteries: Potential as a slow release nitric oxide donor drug, Pharmacol, vol.747, pp.1617-1641, 1997.

I. L. Megson, S. Morton, I. R. Greig, F. A. Mazzei, R. A. Field et al.,

. Substituted-analogues-of-s-nitroso-n-acetyl-d,-l-penicillamine, Chem-750 femoral arteries, Pharmacol, vol.126, pp.639-687, 1999.

,

E. Nozik-grayck, E. J. Whalen, J. S. Stamler, T. J. Mcmahon, and P. Chitano, , p.754

C. A. Piantadosi, S-nitrosoglutathione inhibits alpha1-adrenergic receptor-755 mediated vasoconstriction and ligand binding in pulmonary artery